Eflornithine (α-difluoromethylornithine or DFMO) is a drug manufactured by Sanofi-Aventis which has various uses. It was initially developed as a cancer medication; and while it has no significant effects on cancerous malignancies, it was found to be very effective in combatting African trypanosomiasis (sleeping sickness), in its West African form (Trypanosoma brucei gambiense)Pepin J, Milord F, Guern C, Schechter PJ. Difluoromethylornithine for arseno-resistant Trypanosoma brucei gambiense sleeping sickness. Lancet 1987;2(8573):1431-3. PMID 2891995.
Eflornithine's effects against Trypanosoma brucei gambiense were discovered by chance and because its ability to bring patients back from coma, it became known as "Resurrection Drug".
More on [ Eflornithine ]

Vaniqa - Features, eflornithine hydrochloride, a prescription cream that slows the growth of woman's unwanted facial hair.
Meta Description: [ VANIQA is the first and only prescription cream clinically proven to reduce the growth of unwanted facial hair in women. ]